US Stem Cell Inc (USRM)

[Dragon Lady]

"competition"?? Bioheart is a "competitor" to Neostem?

Neostem is a listed stock w/ a market cap of about $170 million dollars. (BHRT has about an $8.5, maybe $9 milliom market cap and $10 million in debt and trades on the OTC)

Neostem has about 100 plus full time employees, a CEO who's an M.D., and a Sr mgt team of several VP's who are M.D.'s and the rest medical field Ph.d's etc. w/ extensive backgrounds of past medical product development experience and successes (BHRT has 4 full time and maybe 1 part time employee as of latest SEC filings, none of which are an M.D. or have any track record of successfully bringing a medical or drug product to market, no FDA regulatory expertise or past success, etc. per their own listed resumes)

Neostem has about $30 plus million in cash against about $16 million in debt, at least leaving them a net cash position over $10 million. (BHRT had $46 THOUSAND total cash left as of last 10-Q filing, $10 plus million in debt and a "going concern" warning in their latest SEC filing(s))

Neostem has about 35 MILLION total shares outstanding w/ a market cap of about $170 MILLION dollars. (BHRT has about 600 MILLION plus shares outstanding and climbing rapidly, w/ a market cap of maybe $9 MILLION total, w/ debt of $10 MILLION or more)

Neostem has about $16 MILLION in revenues (BHRT, maybe $800K, and that's not from their "key" heart product that's in development, and last qtr's 10-Q showed the cost of sales to be almost as much as the revenue, revenue was $579K, cost of sales was $523K, made no sense IMO)

Neostem's trials are still on-going and moving forward (BHRT's last trials have been parked, the two key, most advanced, the REGEN and MARVEL trials not advancing since 2009/2010 time frame for "lack of funding" and the MIRROR trial enrolled ONE patient then also stalled out for "lack of funding" per their own SEC filings, including the most recent one)

I just don't see how BHRT could really be considered a "competitor" to a company like Neostem? Just don't see that at all IMO.